Victoria Sluzky

Victoria Sluzky is the Chief Technology Officer at Elektrofi, overseeing Pharmaceutical Development and regulatory strategy in support of clinical programs since January 2023. Prior experience includes founding Lucid Biotechnology Advisors LLC, where strategic consultation focuses on early-stage companies in cell and gene therapy and various biotechnology modalities. Victoria held significant roles at BioMarin Pharmaceutical Inc., serving as Senior Vice President in Technical Development, where leadership encompassed global quality and CMC strategy. Earlier career positions span from Director of Analytical Development at Onyx Pharmaceuticals to various roles in pharmaceutical and analytical development at COR Therapeutics and Scios. Victoria received a Ph.D. in Chemical Engineering from the Massachusetts Institute of Technology and a Bachelor of Science in Chemical Engineering from Stanford University.